Premium
Magnetic resonance imaging may be an asset to diagnose and classify fluoroquinolone‐associated Achilles tendinitis
Author(s) -
Gillet P.,
Blum A.,
Hestin D.,
Pourel J.,
Pierfitte C.,
Mainard D.,
Kessler M.,
Netter P.
Publication year - 1995
Publication title -
fundamental and clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.655
H-Index - 73
eISSN - 1472-8206
pISSN - 0767-3981
DOI - 10.1111/j.1472-8206.1995.tb00265.x
Subject(s) - tendinitis , tendinopathy , medicine , magnetic resonance imaging , achilles tendon , orthopedic surgery , t2 weighted , radiology , feature (linguistics) , surgery , tendon , linguistics , philosophy
Summary— The aim of this study was to document the accuracy of magnetic resonance imaging (MRI) during fluoroquinolone‐ associated Achilles tendinitis. Fourteen Achilles tendons were examined by MRI (T1 and T2 or T2*‐weighted sequences) in nine patients with typical tendinopathy (13 cases of tendinitis and 1 rupture) during fluoroquinolone therapy. Tendinous involvement was classified according to the prominence of intra‐ or peritendinous changes. The most typical feature was the presence of intratendinous changes, longitudinal or transversal, detected on T1 or T2‐weighted sequences. Peritendinitis was most visible in two cases and nodular involvement in three cases. It was concluded that MRI appears a helpful and accurate method in identifying and classifying such iatrogenic tendinitis. In addition, MRI indicates orthopedic management when detecting risk of rupture.